Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HIKMA Pharmaceuticals PLC Director's Dealing 2017

Mar 23, 2017

4841_rns_2017-03-23_8f72a673-2dd8-4371-84a4-850906972cdf.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 3051A

Hikma Pharmaceuticals Plc

23 March 2017

Notification and public disclosure of transactions by persons discharging managerial responsibilities

The attached individual notification made under article 19.1 of the Market Abuse Regulation ("MAR") relates to the disposal of Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC by the Chief Strategy and Corporate Development Officer. This announcement is made in accordance with article 19.3 of MAR.

1 Details of the person discharging managerial responsibilities / person closely associated
a) Name Bassam Kanaan
2 Reason for the notification
a) Position/status Chief Strategy and Corporate Development Officer / PDMR
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument and identification code Description: Ordinary shares of 10 pence each

ID Code: GB00B0LCW083
b) Nature of the transaction Disposal of 43,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC.
c) Price(s) and volume(s) Price(s): £21.22

Volume(s): 43,000
d) Aggregated information Aggregated volume: 43,000

Price: £21.22
e) Date of the transaction 20 to 22 March 2017
f) Place of the transaction London Stock Exchange (XLON)

Peter Speirs, Company Secretary, Responsible for releasing this announcement

23 March 2017

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHGCGDXCDDBGRX